These data suggest that asymptomatic, unintentional, single substance exposures to factor Xa inhibitors in patients <6 years of age are unlikely to develop clinically significant bleeding.
Kolbeck et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: